Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

BACKGROUND: Treatment for patients with breast cancer (BC) is guided by human epidermal growth factor receptor 2 (HER2) status. The patient’s HER2 status is assessed using US Food and Drug Administration-approved in vitro diagnostic (IVD) immunohistochemical (IHC) tests and laboratory-developed IVD...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyberg, Mogens, Nielsen, Søren, Røge, Rasmus, Sheppard, Beth, Ranger-Moore, Jim, Walk, Eric, Gartemann, Juliane, Rohr, Ulrich-Peter, Teichgräber, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553016/
https://www.ncbi.nlm.nih.gov/pubmed/26318869
http://dx.doi.org/10.1186/s12913-015-1018-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553016/
https://www.ncbi.nlm.nih.gov/pubmed/26318869
http://dx.doi.org/10.1186/s12913-015-1018-6

Ejemplares similares